CUE
Cue Biopharma
24.70$
-3.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.7% | -12.3% | -21.5% | +5.9% | -28.2% | -30.9% | +82.9% | -22.3% | +33.4% | -26.9% | -0.6% | |
| – | -10.5% | -13.2% | -24.1% | +9.9% | -32.5% | -36.6% | +93.6% | -16.3% | +43.2% | -28.6% | +0.9% | |
| – | -11.3% | -15.4% | -26.8% | +8.0% | -30.7% | -41.5% | +109.3% | -57.4% | +131.9% | -39.6% | +6.2% | |
| – | -11.3% | -15.4% | -26.8% | +8.0% | -30.7% | -41.5% | +109.3% | -32.1% | +45.3% | -39.6% | +6.2% | |
| – | +2.2% | -17.6% | +31.9% | +70.7% | -70.0% | -100.0% | – | +329.7% | +225.7% | -2.6% | +0.4% | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | -6.8% | -2.2% | -13.4% | -6.1% | -24.4% | +6.7% | +43.9% | -18.4% | -14.2% | -41.3% | +206.4% | |
| – | -0.7% | +5.9% | -9.0% | +2.0% | -18.5% | +13.2% | +24.2% | -19.4% | -13.1% | -45.2% | +187.1% | |
| – | -0.4% | -2.2% | -2.2% | -2.2% | +14.8% | -11.7% | -34.8% | -23.0% | -45.2% | -18.3% | +4.2% | |
| – | +41.2% | +11.9% | -0.3% | +65.7% | -56.4% | +34.0% | -4.1% | -35.3% | +68.1% | -15.7% | +12.6% | |
| – | -18.6% | -22.8% | -29.5% | -41.9% | – | – | – | – | – | – | – | |
| – | -13.1% | -19.0% | -28.0% | +17.3% | -31.0% | -62.4% | +176.0% | -27.1% | +99.5% | -18.3% | -89.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | +4.9% | +1.4% | +2.1% | +44.9% | +0.0% | +28.6% | +5.7% | +9.6% | +30.5% | +31.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.